De Gracia J, Rodrigo M J, Morell F, Vendrell M, Miravitlles M, Cruz M J, Codina R, Bofill J M
Servei de Pneumologia, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.
Am J Respir Crit Care Med. 1996 Feb;153(2):650-5. doi: 10.1164/ajrccm.153.2.8564113.
Only a small number of patients with IgG subclass deficiencies (IgGSD) have been observed to have bronchiectasis. Moreover, in the series of patients with bronchiectasis, IgGSD have not been found at any frequency, and the etiology of bronchiectasis remains unclear in 29 to 49% of cases. Serum concentrations of total IgG, IgA, and IgG subclasses as well as pulmonary function were measured in 65 patients (aged: 10 to 74 yr) with bronchiectasis of unknown etiology. An ELISA test was performed to quantify subclasses 1 through 4 using subclass-specific antihuman monoclonal antibodies. IgG subclass estimation in a healthy population with age-stratified normal ranges was derived from 100 adults, 37 children aged between 10 and 12 yr, and 27 adolescents aged between 13 and 16 yr. Serum concentrations of specific IgG antibodies to Haemophilus influenzae type b capsular polysaccharide (Hib-PRP) were also assayed by an ELISA test in 19 of the patients (10 with IgGSD and nine with non-IgGSD) and in 58 healthy individuals before and 3 wk after immunization with Hib-PRP conjugated to meningococcal outer membrane protein complex (OMPC). Thirty-one patients (48%) had low serum concentrations of one or more IgG subclasses (19 IgG2 deficiencies, 2 IgG3 deficiencies, 3 IgG4 deficiencies, and 7 combined subclass deficiencies). All patients showed increased levels of total IgG, IgG1, and IgA, but this rise was significantly higher in patients without IgGSD. Patients with IgGSD showed impaired antibody response to Hib-PRP compared with patients with non-IgGSD and the control group. IgGSD, particularly IgG2 deficiency, are not an unusual cause of bronchiectasis. Therefore, serum levels of IgG subclasses must be assayed whenever other causes of bronchiectasis have been ruled out.
仅观察到少数免疫球蛋白G亚类缺陷(IgGSD)患者患有支气管扩张。此外,在支气管扩张患者系列中,未发现IgGSD有任何特定频率,并且在29%至49%的病例中支气管扩张的病因仍不清楚。对65例病因不明的支气管扩张患者(年龄10至74岁)测定了血清总免疫球蛋白G(IgG)、免疫球蛋白A(IgA)和IgG亚类浓度以及肺功能。使用亚类特异性抗人单克隆抗体进行酶联免疫吸附测定(ELISA)以定量1至4亚类。来自100名成年人、37名10至12岁儿童和27名13至16岁青少年的具有年龄分层正常范围的健康人群的IgG亚类估计值。还通过ELISA试验在19例患者(10例IgGSD患者和9例非IgGSD患者)以及58名健康个体中在接种与脑膜炎球菌外膜蛋白复合物(OMPC)结合的b型流感嗜血杆菌(Hib-PRP)之前和之后3周测定了针对b型流感嗜血杆菌荚膜多糖(Hib-PRP)的特异性IgG抗体的血清浓度。31例患者(48%)有一种或多种IgG亚类的血清浓度较低(19例IgG2缺陷、2例IgG3缺陷、3例IgG4缺陷和7例联合亚类缺陷)。所有患者的总IgG、IgG1和IgA水平均升高,但在无IgGSD的患者中这种升高明显更高。与非IgGSD患者和对照组相比,IgGSD患者对Hib-PRP的抗体反应受损。IgGSD,尤其是IgG2缺陷,并非支气管扩张的罕见病因。因此,每当排除支气管扩张的其他病因时,必须检测IgG亚类的血清水平。